Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a41b5d47dbf55aae

Jump to content

LMO4

From Wikipedia, the free encyclopedia

LMO4
Identifiers
AliasesLMO4, LIM domain only 4
External IDsOMIM: 603129; MGI: 109360; GeneCards: LMO4
Available structures
PDBOrtholog search: PDBe RCSB
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_006769
NM_001369491

NM_001161769
NM_001161770
NM_010723

RefSeq (protein)

NP_006760
NP_001356420

NP_001155241
NP_001155242
NP_034853

Location (UCSC)Chr 1: 87.33 – 87.35 MbChr 3: 143.89 – 143.91 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

LIM domain transcription factor LMO4 is a protein that in humans is encoded by the LMO4 gene.[5]

LIM domain only 4 is a cysteine-rich, two LIM domain-containing protein that may play a role as a transcriptional regulator or possibly an oncogene. Its mRNA is characterized by a GC-rich 5' region and by multiple ATTT motifs in the 3' region. A variant transcript missing a portion of the 5' region has been identified but cannot be confirmed because of the GC-rich nature of the region.[5]

Clinical significance

[edit]

LMO4 has garnered significant attention for its involvement in cancer, particularly breast cancer.[6] It is overexpressed in a substantial percentage of primary breast carcinomas.[7] Studies have shown that LMO4 can promote the proliferation of mammary epithelial cells, inhibit their differentiation, and enhance cell invasion and motility, all of which are hallmarks of cancer progression.

Interactions

[edit]

LMO4 has been shown to interact with LDB1,[8][9] RBBP8[8][10] and BRCA1.[8][10]

References

[edit]
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000143013 – Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000028266 – Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 "Entrez Gene: LMO4 LIM domain only 4".
  6. ↑ Singh RR, Barnes CJ, Talukder AH, Fuqua SA, Kumar R (November 2005). "Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein". Cancer Research. 65 (22): 10594–10601. doi:10.1158/0008-5472.CAN-05-2268. PMID 16288053.
  7. ↑ Sum EY, Segara D, Duscio B, Bath ML, Field AS, Sutherland RL, et al. (May 2005). "Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer". Proceedings of the National Academy of Sciences of the United States of America. 102 (21): 7659–7664. doi:10.1073/pnas.0502990102. PMC 1140463. PMID 15897450.
  8. 1 2 3 Sutherland KD, Visvader JE, Choong DY, Sum EY, Lindeman GJ, Campbell IG (October 2003). "Mutational analysis of the LMO4 gene, encoding a BRCA1-interacting protein, in breast carcinomas". International Journal of Cancer. 107 (1): 155–158. doi:10.1002/ijc.11343. PMID 12925972.
  9. ↑ Deane JE, Mackay JP, Kwan AH, Sum EY, Visvader JE, Matthews JM (May 2003). "Structural basis for the recognition of ldb1 by the N-terminal LIM domains of LMO2 and LMO4". The EMBO Journal. 22 (9): 2224–2233. doi:10.1093/emboj/cdg196. PMC 156068. PMID 12727888.
  10. 1 2 Sum EY, Peng B, Yu X, Chen J, Byrne J, Lindeman GJ, et al. (March 2002). "The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity". The Journal of Biological Chemistry. 277 (10): 7849–7856. doi:10.1074/jbc.M110603200. PMID 11751867.

Further reading

[edit]